Bellerophon Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

SEC filing history

Showing 526-550 of 643 matching filings.

Per page
25
Current page
22
3

FORM 3

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K PEACOCK TENENBAUM

Filing date
23 Feb 2016
Reporting date
21 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
18 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88741

SCHEDULE 13G - BELLEROPHON 2-11-16

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88741

SC 13G filing

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88741

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
27 Jan 2016
Reporting date
25 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
21 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
12 Jan 2016
Reporting date
16 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Dec 2015
Reporting date
15 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
04 Dec 2015
Reporting date
30 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
03 Dec 2015
Reporting date
01 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
30 Nov 2015
Reporting date
23 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
16 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
23 Oct 2015
Reporting date
21 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
23 Oct 2015
Reporting date
21 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
25 Sep 2015
Reporting date
25 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
17 Sep 2015
Reporting date
11 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
09 Sep 2015
Reporting date
09 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .